<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00166829</url>
  </required_header>
  <id_info>
    <org_study_id>920606</org_study_id>
    <nct_id>NCT00166829</nct_id>
  </id_info>
  <brief_title>The Effect of Sirolimus on the Pharmacokinetics of Tacrolimus</brief_title>
  <official_title>The Effect of Sirolimus on the Pharmacokinetics of Tacrolimus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to understand whether the pharmacokinetics of tacrolimus is
      influenced by the concurrent use of sirolimus.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The controlled clinical trial held in NTUH in 2001 revealed that the bioavailability of
      tacrolimus when combined with sirolimus is lower than that reported in the literature where
      tacrolimus was not combined with sirolimus. To determine if the difference was due to the
      drug interaction between sirolimus and tacrolimus, a controlled clinical trial was proposed.

      The purpose of this study is to understand whether the pharmacokinetics of tacrolimus is
      influenced by the concurrent use of sirolimus.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2004</start_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The influence of sirolimus on the pharmacokinetics of tacrolimus in renal transplant patients</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Compare the outcome of tacrolimus/sirolimus and tacrolimus/mycophenolate in rejection prevention</measure>
  </secondary_outcome>
  <enrollment>40</enrollment>
  <condition>Kidney Transplantation</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sirolimus, tacrolimus, mycophenolate mofetil</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  De novo kidney transplant patients

          -  Aged 13 - 65 years

          -  Having aminotransferase concentrations within 2 times the upper limit of normal

        Exclusion Criteria:

          -  Pregnancy

          -  Tuberculosis

          -  Hepatitis B or C carrier status

          -  Human immunodeficiency virus-positive status

          -  Retransplantation or multi-organ transplantation

          -  History of rheumatoid arthritis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Po-Huang Lee, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>National Taiwan University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Meng-Kun Tsai, MD, PhD</last_name>
    <phone>886-2-23123456</phone>
    <phone_ext>5622</phone_ext>
    <email>mark9@ha.mc.ntu.edu.tw</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Fe-Lin L Wu, PhD</last_name>
    <phone>886-2-23123456</phone>
    <phone_ext>8389</phone_ext>
    <email>flwu@ha.mc.ntu.edu.tw</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>100</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Meng-Kun Tsai, MD, PhD</last_name>
      <phone>886-2-23123456</phone>
      <phone_ext>5622</phone_ext>
      <email>mark9@ha.mc.ntu.edu.tw</email>
    </contact>
    <contact_backup>
      <last_name>Fe-Lin L Wu, PhD</last_name>
      <phone>886-2-23123456</phone>
      <phone_ext>8389</phone_ext>
      <email>flwu@ha.mc.ntu.edu.tw</email>
    </contact_backup>
    <investigator>
      <last_name>Meng-Kun Tsai, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>August 2003</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 12, 2005</study_first_submitted>
  <study_first_submitted_qc>September 12, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 14, 2005</study_first_posted>
  <last_update_submitted>March 7, 2007</last_update_submitted>
  <last_update_submitted_qc>March 7, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 8, 2007</last_update_posted>
  <keyword>Tacrolimus</keyword>
  <keyword>Sirolimus</keyword>
  <keyword>Mycophenolic acid</keyword>
  <keyword>Immunosuppressive Agents</keyword>
  <keyword>Immunosuppression</keyword>
  <keyword>Kidney Transplantation</keyword>
  <keyword>Transplantation</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tacrolimus</mesh_term>
    <mesh_term>Sirolimus</mesh_term>
    <mesh_term>Everolimus</mesh_term>
    <mesh_term>Mycophenolic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

